Cambridge University Hospitals NHS Foundation Trust
cuh.nhs.ukTotal trials
164
Active
30
Phase 3
21
Total enrollment
181,543
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tirzepatide | — | — | — | — | 2 | ||
| semaglutide | — | — | — | — | — | 1 | |
| Olaparib | — | — | — | 3 | |||
| Phenytoin Sodium | — | — | — | — | — | 1 | |
| Levetiracetam | — | — | — | — | — | 1 | |
| Ibudilast | — | — | — | — | — | 1 | |
| Paclitaxel and Carboplatin | — | — | — | — | — | 1 | |
| Apalutamide Oral Tablet [Erleada] | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| dapansutrile | — | — | — | — | — | 1 | |
| Aldesleukin | — | — | — | — | 3 | ||
| Interleukin-2 [IL-2] | — | — | — | — | 2 | ||
| Interleukin-2 | — | — | — | — | — | 1 | |
| Anti-Hypertensive medications | — | — | — | — | — | 1 | |
| Dextrose 5% in water | — | — | — | — | — | 1 |
Next readouts
- 2024-06
- 2025-02-01
- 2026-03-01
- 2026-09-01
- 2027-01
- 2027-04
- 2027-04-30
- 2027-07-31
- 2027-08
- 2028-11-01
Top conditions
- Cardiovascular Diseases10
- Breast Cancer9
- Prostate Cancer6
- Covid194
- Microscopic Polyangiitis4
- Stroke4
- Hypertension4
- COVID-194
Frequently asked questions about Cambridge University Hospitals NHS Foundation Trust
- How many clinical trials does Cambridge University Hospitals NHS Foundation Trust have on ClinicalTrials.gov?
- Cambridge University Hospitals NHS Foundation Trust is listed as the lead sponsor on 164 clinical trials in ClinicalTrials.gov, 30 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Cambridge University Hospitals NHS Foundation Trust's trials are in Phase 3?
- 21 of Cambridge University Hospitals NHS Foundation Trust's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does Cambridge University Hospitals NHS Foundation Trust focus on?
- Cambridge University Hospitals NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Cardiovascular Diseases, Breast Cancer, Prostate Cancer, Covid19, Microscopic Polyangiitis.
- When are Cambridge University Hospitals NHS Foundation Trust's next clinical trial readouts?
- Cambridge University Hospitals NHS Foundation Trust has 10 upcoming primary-completion readouts tracked here; the soonest is “Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer”, expected around 2024-06.